Nuwellis (NUWE) to Release Quarterly Earnings on Monday

Nuwellis (NASDAQ:NUWE) will be releasing its earnings data before the market opens on Monday, November 11th. Analysts expect Nuwellis to post earnings of ($0.88) per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Nuwellis (NASDAQ:NUWE) last announced its quarterly earnings data on Tuesday, August 13th. The company reported ($18.85) EPS for the quarter, missing the consensus estimate of ($9.49) by ($9.36). The business had revenue of $2.19 million during the quarter, compared to analysts’ expectations of $1.90 million. Nuwellis had a negative net margin of 232.24% and a negative return on equity of 1,716.60%. On average, analysts expect Nuwellis to post $-10 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Nuwellis Trading Up 2.8 %

NASDAQ:NUWE opened at $1.81 on Friday. The stock has a 50-day moving average price of $1.49 and a 200 day moving average price of $4.08. The stock has a market capitalization of $3.38 million, a P/E ratio of -0.01 and a beta of 0.36. Nuwellis has a 12-month low of $1.00 and a 12-month high of $31.15.

Analysts Set New Price Targets

A number of brokerages recently weighed in on NUWE. Roth Mkm restated a “buy” rating and set a $17.00 target price on shares of Nuwellis in a research report on Tuesday, August 13th. Roth Capital raised shares of Nuwellis to a “strong-buy” rating in a report on Monday, July 29th.

Nuwellis Company Profile

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.